INSIGHTS ON DRUG DEVELOPMENT

• Is Industry Ready To Take A Bite Out Of Obesity?

  What are the clinical, economic, and policy considerations for a class of drugs offering a promising treatment for obesity, and how is the industry adapting to meet demand?

• A Novel Patient-Derived Colorectal Cancer Organoid Platform

  Patient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting therapeutic efficacy. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.

• Unlock Efficiency: Leverage The Right Tools To Build Process Knowledge

  The biopharma industry must shift from data collection to process knowledge, leveraging digital tools to optimize drug development, enhance quality, and streamline tech transfer through digital maturity.

• The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly

  In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.

• Reach Development Goals Faster With Multi-Sample Workflow Technology

  5/4/2024

  Explore the use of Differential Scanning Calorimetry (DSC) multi-sample technology to analyze a variety of pharmaceutical materials and understand critical information for advancing pharma development.

• Navigating Emerging Therapeutics: Cannabinoid And Psilocybin Drug Development

  1/15/2026

  Cannabinoid and psilocybin therapies are advancing rapidly, and Mikart supports innovators with DEA-licensed facilities, formulation expertise, regulatory guidance, and manufacturing capabilities from clinical development to commercialization.

• This Is Where Quality Starts

  3/20/2026

  Quality takes shape long before a workcell ships. Meet the people and processes that ensure consistent performance through every stage of development, and explore how to build reliability into each step.

• Facts About AAV Producer Cell Lines

  8/8/2025

  Gene therapies are revolutionizing medicine, with AAV vectors leading the way. As production evolves, stable cell lines may replace transient transfection and unlock scalable solutions.

• Corticosteroids And Hormonal Therapies — History, Use, And Future Outlook

  2/18/2026

  Explore how evolving science, expanding global demand, and next-generation innovations are reshaping the future of corticosteroid and hormonal therapies — and what this transformation means for the years ahead.